Roll over image to zoom in
Dacihep (Daklinza) Daclatasvir 60mg online
$181.00
Status: In stock
A hepatitis C virus NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic hepatitis C genotype 1 or 3 infection. Sustained virologic response rates are reduced in genotype 3 patients with cirrhosis receiving this combination for 12 weeks.
Dacihep（Daklinza）Daclatasvir 60mg, is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.
Limitations of Use: Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
Dacihep’s brand name is Daklinza by Bristol-Myers Squibb. Dacihep is a generic oncologic prescription medicine from Zydus, which is one of the biggest pharmaceutical company in India.
Limitations of Use: Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
Dacihep’s brand name is Daklinza by Bristol-Myers Squibb. Dacihep is a generic oncologic prescription medicine from Zydus, which is one of the biggest pharmaceutical company in India.
Related products
Recently Viewed Products
